Metastasis is the leading cause of cancer death. A tumor-supportive microenvironment, or premetastatic niche, at potential secondary tumor sites plays an important role in metastasis, especially in tumor cell colonization. Although a fibrotic milieu is known to promote tumorigenesis and metastasis, the underlying molecular contributors to this effect have remained unclear. Here we show that periostin, a component of the extracellular matrix that functions in tissue remodeling, has a key role in formation of a fibrotic environment that promotes tumor metastatic colonization.
Metastasis is the leading cause of cancer death. A tumor-supportive microenvironment, or premetastatic niche, at potential secondary tumor sites plays an important role in metastasis, especially in tumor cell colonization. Although a fibrotic milieu is known to promote tumorigenesis and metastasis, the underlying molecular contributors to this effect have remained unclear. Here we show that periostin, a component of the extracellular matrix that functions in tissue remodeling, has a key role in formation of a fibrotic environment that promotes tumor metastatic colonization.
We found that periostin was widely expressed in fibrotic lesions of mice with bleomycin-induced lung fibrosis, and that up-regulation of periostin expression coincided with activation of myofibroblasts positive for a-smooth muscle actin. We established a lung metastasis model for B16 murine melanoma cells and showed that metastatic colonization of the lung by these cells was markedly promoted by bleomycin-induced lung fibrosis. Inhibition of periostin expression by giving an intratracheal antisense oligonucleotide targeting periostin mRNA was found to suppress bleomycin-induced lung fibrosis and thereby to attenuate metastatic colonization of the lung by melanoma cells. Our results indicate that periostin is a key player in the development of bleomycin-induced fibrosis and consequent enhancement of tumor cell colonization in the lung. Our results therefore implicate periostin as a potential target for prevention or treatment of lung metastasis.
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| INTRODUCTION
Lung metastasis is a major contributor to poor prognosis in many types of cancer, but the mechanisms of such metastasis remain largely unclear.
1,2
The formation of a tumor-supportive microenvironment, or premetastatic niche, by stromal components and immune cells is required for the colonization and propagation of circulating tumor cells at secondary or distant organs. 3 Remodeling of the extracellular matrix (ECM) is key to premetastatic niche formation and is induced by various events such as inflammation and tissue injury. 4 Fibrosis is a result of ECM remodeling. Preclinical data suggest that a fibrotic milieu promotes tumor cell colonization, and smoking, one of the risk factors for pulmonary fibrosis, has been indicated to have an association with lung metastasis in breast cancer patients, 7 although the underlying molecular mechanism of this effect is unknown.
Periostin is a secreted ECM protein that plays various roles in tissue development and regeneration as well as contributing to conditions and diseases such as inflammation, allergy, fibrosis, and cancer. 8 A high level of periostin expression is associated with various types of cancer, including lung, breast, colorectal, and pancreatic cancer as well as melanoma. 9 Periostin is also implicated in lung metastasis of breast cancer as an important component of a cancer stem cell-supportive niche, 10 and it activates a-smooth muscle actin (a-SMA)-positive myofibroblasts and thereby promotes formation of a fibrotic microenvironment to sustain the metastatic growth of pancreatic cancer. 6 We previously reported that high mRNA expression of POSTN, FN1, and COL1A1 was detected in the metastatic region of a melanoma patient by gene expression analysis, and that periostin was highly expressed during the wound-healing process. 11 Periostin was considered to be the most feasible therapeutic target among these ECM proteins because mice deficient in Fn1 or Col1a1 are embryonic lethal 12, 13 whereas mice deficient in Postn develop normally. Thus, we showed that inhibition of periostin significantly reduced the incidence of melanoma metastasis to wound sites.
11
Although periostin is known to be an essential factor for fibrotic responses in idiopathic interstitial pneumonia in both mice and humans, 14, 15 the relation between its role in lung fibrosis and lung metastasis of tumor cells is not well defined.
We have now established mice with pulmonary fibrosis induced by bleomycin as a lung metastasis model for melanoma.
We found that fibrosis enhanced metastatic colonization of the lung of these animals by B16 murine melanoma cells, and that periostin contributed to formation of this premetastatic niche through activation of a-SMA + myofibroblasts. Furthermore, giving an intratracheal antisense oligonucleotide that targets periostin mRNA attenuated periostin expression as well as suppressed bleomycin-induced lung fibrosis and metastatic colonization of the lung by melanoma cells.
| MATERIALS AND METHODS

| Mice
Female C57BL/6J mice aged 6-10 weeks (Sankyo Labo Service Corporation, Tokyo, Japan) were studied. All animal experiments were carried out in accordance with protocols approved by the Ethics Committee of Keio University.
| Cell lines
Murine melanoma cell lines B16 and B16-BL6 were obtained from RIKEN Cell Bank (Tsukuba, Japan). Cells were cultured in DMEM supplemented with 10% FBS and penicillin-streptomycin (Nacalai Tesque, Kyoto, Japan). for each of at least 3 mice per group were assessed for tumor size, cell counts, and severity of fibrosis based on the Ashcroft score. 17 
| Antisense oligonucleotides
| Statistical analysis
Data are presented as means AE SD and were analyzed with Student's t test or one-way ANOVA followed by Dunnett's multiple comparison test as carried out with GraphPad Prism version 6. Pvalue of <.05 was considered statistically significant.
| Additional methods
Isolation and culture of murine lung fibroblasts, in vivo studies for analysis of the effect of giving ASO on metastasis by B16-BL6, quantitative RT-PCR analysis, and periostin ASO treatment in vitro are described in Appendix S1.
3 | RESULTS
| Expression of periostin and number of a-
SMA + cells increase with progression of bleomycininduced lung fibrosis
To examine the relation between fibrotic change and periostin expression in mouse lung, we studied a well-characterized mouse model of lung fibrosis based on bleomycin treatment. 18 C57BL/6J mice that received a single intratracheal injection of bleomycin were subjected to histological analysis of the lung every 4 days for up to 16 days ( Figure 1A ). An increase in interstitial thickness was apparent from day 4 and was followed by an increase in fibrosis, with marked accumulation of connective tissue and collapse of alveolar structure being observed from day 12. Ashcroft score for severity of fibrosis was significantly increased from day 8 to day 16 compared with that at day 0 ( Figure 1B) . Progression of lung fibrosis was accompanied by a pronounced increase in the number of periostin + cells that was first apparent at day 8 ( Figure 1A ,C). Number of a-SMA + myofibroblasts, which are key mediators of fibrosis, 19 was also increased in fibrotic lesions at day 8 but had decreased again at day 12 ( Figure 1D ,E). To clarify the role of periostin in lung fibrosis induced by bleomycin,
we gave an ASO targeting periostin mRNA to inhibit periostin expression. 20 We confirmed that periostin ASO suppressed Postn mRNA expression in lung fibroblasts in vitro ( Figure S2 ). Mice were thus injected intratracheally with a control or periostin ASO on day 2 and day 7 after receiving bleomycin, and the lung was subjected to histological analysis on day 8. We found that periostin ASO treatment attenuated lung fibrosis as well as periostin expression induced by bleomycin ( Figure 3A ). Both the Ashcroft score and the percentage of periostin + cells were thus significantly lower in the mice treated with periostin ASO than in those that received control ASO ( Figure 3B,C) . The number of a-SMA + cells in fibrotic lesions was also reduced by periostin ASO treatment ( Figure 3D ). Of note, cells positive for both Ki-67 and a-SMA, corresponding to proliferating myofibroblasts, were observed less frequently in fibrotic loci of periostin ASO-treated mice ( Figure 3E ). These data suggested that periostin plays a key role in the development of lung fibrosis and myofibroblast activation in response to bleomycin. 
| DISCUSSION
We have herein confirmed that periostin is widely expressed in fibrotic lesions of C57BL/6J mice with bleomycin-induced lung fibrosis. Periostin expression has previously been shown to be up-regulated in lung mesenchymal cells such as fibroblasts and fibrocytes in mice treated with bleomycin, 21 in monocytes, fibrocytes, and fibroblasts of the lung in patients with idiopathic pulmonary fibrosis, 15 and in bronchial epithelial cells of such patients and individuals with asthma. 22 Bleomycin treatment has also been found to increase the expression of various inflammatory mediators including transforming growth factor-b1 (TGF-b1), interleukin (IL)-4, and IL-13. 23 Up-regulation of periostin production in lung cells might thus be mediated through activation of TGF-b or JAK-STAT signaling pathways. 21, 24 Myofibroblasts play the leading role in tissue remodeling and production of ECM during lung fibrogenesis. Consistent with this scenario, we found that the number of a-SMA + myofibroblasts increased concomitantly with that of periostin + cells in the lung of bleomycin-treated mice. Myofibroblasts that originate from resident stromal cells are activated by various stimuli including chemokines, ECM proteins, and mechanical stress. 25 Periostin up-regulates a-SMA expression in murine skin fibroblasts through activation of integrin-FAK signaling. 26 Periostin also promotes the induction of myofibroblast differentiation by cytokines such as TGF-b1 and connective tissue growth factor, the latter of which is secreted from lung mesenchymal cells in response to bleomycin stimulation. 21 Peri- . All quantitative data are means AE SD for 4 mice in each group. **P < .01, ***P < .001 (one-way ANOVA)
cytokines and immune cells, 27 and only a few of those that survive go on to give rise to macrometastases. 28 ROS is known to be a major contributor to prevention of tumor cell metastasis. It is known that some kinds of ECM proteins such as laminin and fibronectin stimulate the generation of ROS by integrin-mediated signaling pathway. 29 In contrast, fibulin-5 reduced ROS production in pancreatic cancer cells by competing with fibronectin for binding to integrin. 30 Therefore, an ECM protein periostin might also be involved in the regulation of ROS level in the premetastatic niche. An experimental mouse model showed that only 0.02% of melanoma cells injected into the portal vein were able to form multicellular foci in the liver. 31 Similarly, we found that macrometastases in saline-treated mouse lung were rarely observed after tail vein injection of B16 melanoma cells. In contrast, a large number of macrometastases was evident in the bleomycin-treated lung, suggesting that the genera- In summary, our results provide evidence that periostin is an essential molecule for generation of bleomycin-induced lung fibrosis.
F I G U R E 3 Effects of giving periostin antisense oligonucleotides (ASO) on the bleomycin-treated lung. A, Mice were injected intratracheally with a control or periostin ASO at 2 and 7 d after receiving bleomycin and were killed for analysis on day 8. Serial sections of the lung were stained with hematoxylin-eosin (H&E) and subjected to immunohistochemical analysis of periostin expression. Scale bars, 100 lm. B, Ashcroft score for lung fibrosis in the mice on day 8. C, Quantification of the percentage of periostin-positive cells in the lung on day 8. D, Lung sections from the mice on day 8 were subjected to immunohistochemical analysis for quantification of the density of a-smooth muscle actin (a-SMA)-positive cells in fibrotic areas. Scale bars, 100 lm. E, Representative immunohistofluorescence staining of lung fibrotic lesions for a-SMA and Ki-67 at day 8. Nuclei were stained with DAPI. Scale bars, 100 and 10 lm for low-magnification and high-magnification (insets) images, respectively. All quantitative data are means AE SD for 8 and 6 mice injected with the control or periostin ASO, respectively. *P < .05 (Student's t test)
Our results suggest that periostin promotes metastatic colonization of the lung by melanoma cells. Furthermore, ASO-based therapies that target periostin have the potential to suppress metastatic colonization by preventing the formation of a fibrotic milieu able to serve as a premetastatic niche.
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